|
|||||
|
|
1118‐20, an indazole diarylurea compound,inhibits hepatocellular carcinoma HepG2 proliferation and tumour angiogenesis involving Wnt/β‐catenin pathway and receptor tyrosine kinases |
|
| Authors: | Yu‐Yin Lu Jing‐Jing Wang Xin‐Ke Zhang Wen‐Bao Li Xiu‐Li Guo |
| Affiliation: | 1. Department of Pharmacology, School of Pharmaceutical Sciences, Shandong University, Jinan, China;2. School of Medicine and Pharmacy, Ocean University of China, Qingdao, China |
| Abstract: | |
| Keywords: | 1118‐20 proliferation sorafenib tumour angiogenesis Wnt/β ‐catenin pathway |